Niagen Bioscience Inc (NAGE) quarterly cash flow statement — complete operating, investing & financing history
| Cash from Operations | -1.19M | 624K | 3.69M | 1.25M | 7.88M | 8.58M | 3.5M | -264K | 295K | 649K | 396K | 3.28M |
| Operating CF Margin % | -3.79% | 1.84% | 10.86% | 4.02% | 25.86% | 29.47% | 13.66% | -1.16% | 1.33% | 3.06% | 2.03% | 16.14% |
| Operating CF Growth % | -115.15% | -92.73% | 5.64% | 573.48% | 2572.2% | 1222.5% | 782.58% | -108.05% | -89.43% | 297.87% | 110.59% | 185.59% |
| Net Income | 6.32M | 4.13M | 4.58M | 3.61M | 5.06M | 7.18M | 1.88M | -15K | -492K | 114K | -959K | -2.19M |
| Depreciation & Amortization | 291K | 864K | 195K | 355K | 368K | 358K | 366K | 370K | 390K | 373K | 448K | 444K |
| Stock-Based Compensation | 0 | 0 | 0 | 1.49M | 1.07M | 752K | 735K | 1.19M | 984K | 1.04M | 1.12M | 1.32M |
| Deferred Taxes | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Cash Items | -2.68M | -703K | 1.92M | 102K | -1.37M | -4.9M | 13K | 33K | 56K | 37K | 212K | 418K |
| Working Capital Changes | -5.12M | -3.67M | -3M | -4.3M | 2.75M | 5.19M | 503K | -1.84M | -643K | -912K | -422K | 3.29M |
| Change in Receivables | -3.41M | -1.26M | 1.16M | -2.69M | 2.04M | 642K | 710K | -1.23M | -1.41M | 348K | 323K | 2.67M |
| Change in Inventory | -3.57M | -2.04M | -4.38M | -3.22M | -1.99M | 1.35M | 967K | 984K | 2.03M | -1.9M | -651K | -65K |
| Change in Payables | 2.48M | -1.95M | -938K | 3.05M | 2.11M | 2.26M | -1.2M | 206K | -2.33M | 1.03M | -833K | 1.08M |
| Cash from Investing | 5.25M | -101K | -24K | -135K | -32K | -69K | -21K | -12K | -41K | -21K | -26K | -5K |
| Capital Expenditures | -61K | -101K | -24K | -135K | -32K | -69K | -41K | -12K | -41K | -21K | -26K | -10K |
| CapEx % of Revenue | 0.19% | 0.3% | 0.07% | 0.43% | 0.1% | 0.24% | 0.16% | 0.05% | 0.19% | 0.1% | 0.13% | 0.05% |
| Acquisitions | 5.31M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 0 | 0 | 0 | 0 | 0 | 0 | 20K | 0 | 0 | 0 | 0 | 5K |
| Cash from Financing | -2.29M | -25K | 148K | 3.74M | 3.1M | 3.75M | 1.04M | 596K | -14K | -76K | -3K | -10K |
| Debt Issued (Net) | 0 | -2K | -4K | -3K | -3K | -2K | -4K | -2K | -3K | -1K | -3K | -10K |
| Equity Issued (Net) | -2.24M | -23K | 152K | 3.75M | 3.11M | 3.79M | 1.04M | 598K | 0 | 0 | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | -2.35M | -251K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing | -47K | 0 | 0 | -6K | -6K | -41K | 0 | 0 | -11K | -75K | 0 | 0 |
| Net Change in Cash | 1.76M | 498K | 3.82M | 4.86M | 10.96M | 12.26M | 4.51M | 320K | 240K | 552K | 367K | 3.27M |
| Free Cash Flow | -1.25M | 523K | 3.67M | 1.11M | 7.85M | 8.51M | 3.45M | -276K | 254K | 628K | 370K | 3.27M |
| FCF Margin % | -3.99% | 1.55% | 10.79% | 3.58% | 25.76% | 29.23% | 13.5% | -1.21% | 1.15% | 2.96% | 1.9% | 16.09% |
| FCF Growth % | -115.99% | -93.86% | 6.2% | 503.99% | 2990.94% | 1255.73% | 833.51% | -108.44% | -90.6% | 225.6% | 109.76% | 183.48% |
| FCF per Share | -0.01 | 0.01 | 0.04 | 0.01 | 0.09 | 0.10 | 0.04 | -0.00 | 0.00 | 0.01 | 0.00 | 0.04 |
| FCF Conversion (FCF/Net Income) | -0.19x | 0.15x | 0.81x | 0.35x | 1.56x | 1.20x | 1.86x | 17.60x | -0.60x | 5.69x | -0.41x | -1.50x |
| Interest Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |